Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
radiotherapy 41.4Gy/23fraction
2 trials
Sponsors
Shandong Cancer Hospital
Conditions
Esophageal cancer
esophageal cancer
Phase 1
Radiotherapy and Toripalimab for Neoadjuvant Treatment of Resectable Esophageal Cancer
Active, not recruiting
ChiCTR1900022282
Shandong Cancer Hospital
esophageal cancer
Start: 2019-04-10
Updated: 2019-04-08
Phase 2
Neoadjuvant Radiotherapy combined with Toripalimab for Resectable Esophageal Squamous Cell Cancer: a phase Ib/II trial
Active, not recruiting
ChiCTR2500112131
Shandong Cancer Hospital
Esophageal cancer
Start: 2019-10-12
Updated: 2025-11-17
Related Papers
Safety and Tolerability of Neoadjuvant Radiotherapy Combined With Anti-PD-1 Antibody Toripalimab for Locally Advanced, Resectable Esophageal Squamous Cell Cancer: A Prospective Phase IB Trial.
2021-11-01